Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark Voskoboynik
‘Charting a New Course for Prostate Cancer’ – Currying Favor for Docetaxel in Hormone-Sensitive Metastatic Prostate Cancer
Expert Review of Anticancer Therapy
Oncology
Pharmacology
Related publications
Chemohormonal Therapy for Metastatic Hormone-Sensitive Prostate Cancer: An Asian Perspective
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Eyeing Enzalutamide for Hormone-Sensitive Prostate Cancer
Cancer Discovery
Oncology
New Possibilities of Combined Antiandrogen Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Onkourologiya
Oncology
Radiology
Urology
Nuclear Medicine
Nephrology
Imaging
Surgery
Low-Dose Docetaxel in Combination With Dexamethasone for Hormone-Refractory Prostate Cancer
Japanese Journal of Urology
Urology
Management of Docetaxel Failures in Metastatic Castrate-Resistant Prostate Cancer
Urologic Clinics of North America
Urology
Cost-Effectiveness Analysis of Abiraterone, Docetaxel or Placebo Plus Androgen Deprivation Therapy for Hormone-Sensitive Advanced Prostate Cancer
Einstein (São Paulo, Brazil)
Medicine
Estimating Utilities / Disutilities for High Risk Metastatic Hormone-Sensitive Prostate Cancer (MHSPC) and Treatment-Related Adverse Events
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Hormone-Refractory Prostate Cancer
Prostate-Specific Membrane Antigen–Directed Therapy for Metastatic Castration-Resistant Prostate Cancer
Cancer Journal
Cancer Research
Oncology